Design, synthesis, and characterization of fluorescent cobalamin analogues with high quantum efficiencies

Organic Letters

Volumn 11, Issue 12, 2009, Pages 2499-2502

  Lee, Manfai ^a   Grissom, Charles B ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; CYCLOHEXANE DERIVATIVE; DNA; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FLUORESCENT DYE; RHODAMINE; RHODAMINE 6G; TUMOR MARKER;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; HUMAN; METABOLISM; QUANTUM THEORY; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CYCLOHEXANES; DNA; DRUG DESIGN; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; MOLECULAR STRUCTURE; QUANTUM THEORY; RHODAMINES; TUMOR MARKERS, BIOLOGICAL; VITAMIN B 12;

EID: 67149095013     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900401z     Document Type: Article

References (19)

1. (a) Hogenkamp, H. P. C.; Collins, D. A.; Grissom, C. B.; West, F. G. Chemistry and Biochemistry of B12; John Wiley and Sons: New York, 1999; pp 385
2. (b) Kunze, S.; Zobi, F.; Kurz, P.; Spingler, B.; Alberto, R. Angew. Chem., Int. Ed. 2004, 43, 5025
3. (c) Flodh, H. Acta Radiol. Suppl. 1968, 284, 1
4. (d) Hall, C. A. J. Lab. Clin. Med. 1984, 103, 70
5. (e) Collins, D. A.; Hogenkamp, H. P. C.; O'Connor, M. K.; Naylor, S.; Benson, L. M.; Hardman, R.; Thorson, L. M. Mayo Clin. Proc. 2000, 75, 568.
6. Cannon, M. J. Ph. D. Thesis. University of Utah. Salt Lake City, UT, 2001.
7. Horton, R. A. Ph. D. Thesis. University of Utah, Salt Lake City, UT. 2004.
8. Smeltzer, C. C.; Cannon, M. J.; Pinson, P. R.; Munger Jr, J. D.; West, F. G.; Grissom, C. B. Org. Lett. 2001, 5, 799.
9. Martin, B. D.; Finke, R. G. J. Am. Chem, Soc., 1992, 114, 585.
10. (a) Fedosov, S.; Laursen, N. B.; Moestrup, S. K.; Nexo, E.; Petersen, T. E.; Jensen, E. O.; Berglund, L. Biochemistry 2004, 42, 15095
11. (b) Fedosov, S.; Dedosova, N. U.; Nexo, E.; Petersen, T. E. J. Biol. Chem. 2000, 275, 11791.
12. (a) Pathare, P. M.; Wilbur, D. S.; Heusser, S.; Quadros, E. V.; McLoughlin, P.; Morgan, A. C. Bioconjugate Chem. 1996, 7, 217
13. (b) Wuerges, J.; Garau, G.; Geremia, S.; Fedosov, S. N.; Petersen, T. E.; Randaccio, L. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4386.
14. This procedure yields an isomeric mixture of the 5- and 6-carboxy-fluoresceins. Use of this mixture of isomers is common in the construction of fluorescein-based imaging agents, (a) Orndroff, W. R.; Hemmerm, A. J. Am. Chem. Soc. 1927, 49, 1272
15. (b) Sun, W.-C.; Gee, K. R.; Klaubert, D. H.; Haughland, R. P. J. Org. Chem. 1997, 62, 6469.
16. Adamczyk, M.; Fishpaugh, J. R.; Heuser, K. J. Bioconjugate Chem. 1997, 8, 253.
17. (a) Nguyen, T.; Francis, M. B. Org. Lett. 2003, 5, 3245
18. (b) Adamczyk, M.; Grote, J. J. Bioorg. Med. Chem. Lett. 2000, 10, 1539
19. (c) Adamczyk, M.; Grote, J. Synth. Commun. 2001, 31, 2681.